Business Wire

Panasonic Develops World's First*1 Continuous Wave 4.5 W High-Power Blue-Violet Semiconductor Laser

Del

Panasonic Corporation today announced that it has developed a blue-violet semiconductor laser operating at output power of 4.5 W, which is 1.5 times higher than that of the conventional one even at 60ºC, the maximum operating temperature for lasers in general.  It can also oscillate with the high energy conversion efficiency, which is 1.2 times higher than that of conventional lasers. This has been made possible by Panasonic’s unique double heat flow packaging technology that improves the heat dissipation. This newly-developed laser will help laser application systems, such as vehicle and industrial lighting as well as laser machining equipment, to be made smaller and consume less power.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20150930005736/en/

In general, the output power of semiconductor lasers decreases as the laser chip temperature rises. In addition, because the temperature is the determining factor for the laser reliability (because the laser function reliability is dependent on the laser chip temperature), the actual light output that can be used in practical applications is limited by the laser chip temperature. Conventional blue-violet lasers dissipate heat from only one side of the laser chip, causing the laser chip temperature to increase and limiting the output to approximately 3 W. Laser systems requiring an output of tens of watts would require a large number of lasers, causing more heat to be generated and requiring larger heatsinks. To solve this challenge, individual lasers require higher efficiency and larger output.

The newly-developed double heat flow packaging technology can suppress the temperature increase of laser chip that accompanies laser beam output. Consequently, the drop in laser light output caused by heat can also be prevented, enabling high-output and high-efficiency operation. As a result, in laser systems using multiple lasers, the number of lasers can be reduced to two-thirds of those using conventional lasers. Moreover, because the heatsinks can be smaller, the system itself can be made smaller and lighter.

This new development laser has the following features:

High output:
Maximum light output of 4.5 W (1.5 times higher than existing product*2)

High power conversion efficiency:
33% (1.2 times higher than existing product*3)

High reliability:
Reduced strain in blue-violet semiconductor laser chip, achieving stable output

This device has been made possible through the following technologies:

  • Excellent heat dissipation structure realized by forming heat flow paths on both sides of the laser chip, thus increasing heat conduction from the laser-chip to 1.6 times that of the existing product (Thermal resistance: 6.6 K/W for new product, 10.5 K/W for existing product)
  • Low-strain heat dissipation block structure using aluminum nitride, which has the almost same coefficient of thermal expansion as the laser chip

On the new high-output blue-violet semiconductor laser technology, Panasonic holds 23 patents in Japan and 31 patents overseas including pending applications.

Panasonic presented the research results at 2015 International Conference on Solid State Devices and Materials to be held in Sapporo, Japan on September 28.

This work is partially supported by the New Energy and Industrial Technology Development Organization (NEDO), Japan, under the Strategic Innovation Program for Energy Conservation Technologies.

 
*1   Under a state of continuous wave operation at 60ºC with the practical operation. (as of September 29, 2015; Source: Panasonic)
*2 Compared with a Panasonic developed laser with a conventional structure (at operating temperature of 60ºC)
*3 At operating temperature of 60ºC, light output of 3 W
 

About Panasonic

Panasonic Corporation is a worldwide leader in the development of diverse electronics technologies and solutions for customers in the consumer electronics, housing, automotive, enterprise solutions and device industries. Since its founding in 1918, the company has expanded globally and now operates 468 subsidiaries and 94 associated companies worldwide, recording consolidated net sales of 7.715 trillion yen for the year ended March 31, 2015. Committed to pursuing new value through innovation across divisional lines, the company uses its technologies to create a better life and a better world for its customers. To learn more about Panasonic: http://www.panasonic.com/global.

Contact information

Media Contacts:
Public Relations Department
Panasonic Corporation
Tel: +81-(0)3-3574-5664 Fax: +81-(0)3-3574-5699
Panasonic News Bureau
Tel: +81-(0)3-3542-6205 Fax: +81-(0)3-3542-9018

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Celltrion Receives Positive CHMP Opinion for Herzuma® for Trastuzumab Biosimilar15.12.2017 22:13Pressemelding

Celltrion, Inc. (KOSDAQ: 068270) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a positive opinion recommending that Herzuma® (trastuzumab biosimilar) be granted marketing authorization in the European Union (EU) for the treatment of patients with early breast cancer, metastatic breast cancer, or metastatic gastric cancer whose tumors have either HER2 overexpression or HER2 gene amplification. The CHMP’s opinion will now be sent to the European Commission (EC) for final review. Herzuma® is a biosimilar to Herceptin®i, a breast cancer and gastric cancer treatment antibody biologic drug developed by Genentech and marketed by Roche. Herceptin® is a blockbuster drug which had worldwide sales of CHF 6.8 billionii (US$6.8 billion) in 2016, of which CHF 2.1 billioniii (US$2.1 billion) was in

Takeda and TiGenix announce that Cx601 (darvadstrocel) has received a positive CHMP opinion to treat complex perianal fistulas in Crohn’s disease15.12.2017 12:34Pressemelding

Takeda Pharmaceutical Company Limited (TSE: 4502) (“Takeda”) and TiGenix NV (Euronext Brussels and NASDAQ: TIG) (“TiGenix”) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA), in conjunction with the Committee for Advanced Therapies (CAT), has adopted a positive opinion recommending a marketing authorization (MA) for investigational compound Cx601 (darvadstrocel). Cx601 is expected to be indicated for the treatment of complex perianal fistulas in adult patients with non-active/mildly active luminal Crohn’s disease, when fistulas have shown an inadequate response to at least one conventional or biologic therapy.2 This recommendation marks the first allogeneic stem cell therapy to receive a positive CHMP opinion in Europe. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/201712

Bitcoin Romania and Twispay Announce Integration Partnership Providing Users with the Ability to Purchase Bitcoin with Bank Cards15.12.2017 12:21Pressemelding

Bitcoin Romania, leading Eastern European Bitcoin exchange & brokerage firm, and Twispay, Swiss-owned European payment processor and FinTech pioneer, today announced the availability of a payment integration that allows a global clientele to acquire Bitcoin and Ethereum cryptocurrencies using Visa and Mastercard bank cards. Unprecedented in Romania, this is one of the first East-Central European integration partnerships that allow consumers to use their cards to purchase cryptocurrency. Until recently, investors could only acquire cryptocurrencies through bank transfers and cash deposits, but the volatility of cryptocurrency markets dictates the need for additional operational flexibility. Investors require faster, safer, more reliable, and more comfortable ways to complete purchases. “One minute can make the difference between a million lost and a million earned. That is pr

Upon Conclusion of the Fourth Annual Forum for Promoting Peace in Muslim Societies, Scholars and Intellectuals Visit the Louvre Abu Dhabi Museum15.12.2017 11:38Pressemelding

A high-level delegation of dignitaries, scholars and intellectuals participating in the fourth annual Forum for Promoting Peace in Muslim Societies, visited the Louvre Abu Dhabi museum. The delegation was headed by H.E Mustafa Ceric, former Grand Mufti of Bosnia; alongside Sheikh Mohammad Mukhtar Ould Imbala, Head of Mauritania’s Fatwa & Grievances Supreme Council; H.E Amar Mirghani Hussein, Sudanese Minister of (religious) Guidance and Endowments; and H.E Salho Jay, Imam of the Juma Masjid in South Africa. The Forum was held in Abu Dhabi from 11-13 December 2017, with the participation of more than 700 scholars, intellectuals and religious dignitaries from around the world. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171215005255/en/ Group Photo of the Scholars and Intellectuals during their visit to the L

Kennedy Wilson Acquires 124-Unit Northbank Apartments in Dublin, Ireland for €45 Million15.12.2017 11:00Pressemelding

Global real estate investment company Kennedy Wilson (NYSE: KW) announces that it has acquired Northbank Apartments, a wholly-owned 124-unit apartment community in Dublin’s North Docks, for €45 million from Jarmar Properties Limited (In Receivership) acting through David Carson of Deloitte as Statutory Receiver, the lender being the National Asset Management Agency (“NAMA”). Situated in Dublin’s North Docks, Northbank is located just 50 meters from Kennedy Wilson’s existing 84-unit Liffey Trust apartments. The two buildings benefit from great transport links as the LUAS Red line is immediately adjacent connecting to Dublin’s city centre and main train stations in five minutes. “The successful acquisition of Northbank in such close proximity to our Liffey Trust asset allows us to leverage our existing presence and implement our value-add asset management strategy, including a

AML BitCoin Enters Phase II of ICO15.12.2017 09:00Pressemelding

NAC Foundation, LLC announces today that the initial coin offering for the AML BitCoin – the world’s only patent-pending compliant digital currency – has been extended for another month to accommodate a torrent of last minute, new coin purchasers and the demands of thousands of current owners of the coin, who have had difficulty navigating the process of establishing the specialized wallet required to hold the innovative digital currency. This second phase of the AML BitCoin initial coin offering will see an increase in the price of the coin, from US $1.00 to US $1.25. The company has already been contacted by prospective purchasers in the slightly higher priced Phase II, and anticipates a further price increase to US $1.50 within a week or two. HitBTC, one of the world’s largest and most active digital currency exchanges, was prepared to list the AML BitCoin for trading on

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom